Application

INSITE

Clinical Financial Services, LLC

Trademark/Service Mark Application, Principal Register

PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 12/31/2014)

Trademark/Service Mark Application, Principal Register

Serial Number: 85654186
Filing Date: 06/18/2012

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85654186
MARK INFORMATION
*MARK INSITE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT INSITE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font, style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Clinical Financial Services, LLC
DBA/AKA/TA/Formerly DBA CFS Clinical
INTERNAL ADDRESS 1st Floor
*STREET 1000 Madison Avenue
*CITY Audubon
*STATE
(Required for U.S. applicants)
Pennsylvania
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. applicants only)
19403
WEBSITE ADDRESS www.clinicalfinancialservices.com
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED Pennsylvania
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 035 
*IDENTIFICATION Clinical trial management services, namely, development of investigator grant budgets, negotiation and administration of investigator grants, and negotiation and administration of clinical trial agreements; business management services in the field of clinical trials, namely, compilation and management of information required for regulatory submissions
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 036 
*IDENTIFICATION Financial services, namely administering payments in compliance with contracts in connection with the conducting of clinical trials; financial consulting services relating to facilitation and management of clinical trials
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Software as a Service (SAAS) services featuring software for managing the administrative and financial aspects of clinical trials
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Gregory S. Bernabeo
ATTORNEY DOCKET NUMBER 018537.96592
FIRM NAME Saul Ewing LLP
INTERNAL ADDRESS 38th Floor
STREET 1500 Market Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19102
PHONE 215-972-7755
FAX 215-972-4156
EMAIL ADDRESS trademarks@saul.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Mark D. Simpson, Stephen J. Driscoll
CORRESPONDENCE INFORMATION
NAME Gregory S. Bernabeo
FIRM NAME Saul Ewing LLP
INTERNAL ADDRESS 38th Floor
STREET 1500 Market Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19102
PHONE 215-972-7755
FAX 215-972-4156
EMAIL ADDRESS trademarks@saul.com;gbernabeo@saul.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
NUMBER OF CLASSES 3
FEE PER CLASS 325
*TOTAL FEE DUE 975
*TOTAL FEE PAID 975
SIGNATURE INFORMATION
SIGNATURE /G.J Seminack/
SIGNATORY'S NAME Gregory Seminack
SIGNATORY'S POSITION President
DATE SIGNED 06/18/2012



PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 12/31/2014)


Trademark/Service Mark Application, Principal Register

Serial Number: 85654186
Filing Date: 06/18/2012

To the Commissioner for Trademarks:

MARK: INSITE (Standard Characters, see mark)
The literal element of the mark consists of INSITE.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Clinical Financial Services, LLC, DBA CFS Clinical, a limited liability company legally organized under the laws of Pennsylvania, having an address of
      1st Floor,
      1000 Madison Avenue
      Audubon, Pennsylvania 19403
      United States


requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 035:  Clinical trial management services, namely, development of investigator grant budgets, negotiation and administration of investigator grants, and negotiation and administration of clinical trial agreements; business management services in the field of clinical trials, namely, compilation and management of information required for regulatory submissions
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

       International Class 036:  Financial services, namely administering payments in compliance with contracts in connection with the conducting of clinical trials; financial consulting services relating to facilitation and management of clinical trials
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

       International Class 042:  Software as a Service (SAAS) services featuring software for managing the administrative and financial aspects of clinical trials
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).


For informational purposes only, applicant's website address is: www.clinicalfinancialservices.com

The applicant's current Attorney Information:
      Gregory S. Bernabeo and Mark D. Simpson, Stephen J. Driscoll of Saul Ewing LLP

      38th Floor
      1500 Market Street
      Philadelphia, Pennsylvania 19102
      United States
The attorney docket/reference number is 018537.96592.
The applicant's current Correspondence Information:
      Gregory S. Bernabeo
      Saul Ewing LLP
      38th Floor
      1500 Market Street
      Philadelphia, Pennsylvania 19102
      215-972-7755(phone)
      215-972-4156(fax)
      trademarks@saul.com;gbernabeo@saul.com (authorized)

A fee payment in the amount of $975 has been submitted with the application, representing payment for 3 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /G.J Seminack/   Date: 06/18/2012
Signatory's Name: Gregory Seminack
Signatory's Position: President
RAM Sale Number: 10880
RAM Accounting Date: 06/18/2012

Serial Number: 85654186
Internet Transmission Date: Mon Jun 18 12:05:45 EDT 2012
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2012061812054506
8807-85654186-4905a42a069fcaf94c14cd6cdb
a96c88-DA-10880-20120618110931322861

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed